X
Axabin

Axabin (Rivaroxaban)

  • Generic name: Rivaroxaban
  • Pharmacologic Category: Anticoagulant
  • Dosage Forms: Oral Film-coated tablets, 2.5 mg
  • Mechanism of Action: A direct, selective inhibitor of Factor Xa
  • Indications
  • Benefits of Axabin
  • Contraindications
  • Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers
  • Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischemic events.
  • New generation of anticoagulants
  • No routine coagulation monitoring required (INR test)
  • Fewer drug-drug interactions
  • No food – drug interactions
  • Axabin is taken once a day. (The dose is determined based on the patient's creatinine clearance.)
  • No frequent dose adjustment based on age, sex and weight
  • Pregnancy and Breast-Feeding
  • severe hepatic impairment
  • Serious hypersensitivity to Axabin or any component of the formulation
  • Severe and active bleeding
  • Patients who are under 18 years’ old

About Axabin 2.5:

Rivaroxaban is a highly selective direct factor Xa inhibitor with oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.

 

 

Did you know more than 27 per 1000 diabetic patients were died annually caused by cardiovascular diseases.

Did you know…

Do you know, what percentage of diabetic patients get amputations due to PAD?

Throughout the world, it is estimated that every 30 seconds a leg is amputated. And 85% of these amputations were the result of peripheral artery disease and then diabetic foot ulcer.

SPECIFIC ADVANTAGES:

  • Easy oral administration
  • Once daily dosing
  • No requirement for routine coagulation monitoring
  • Demonstrated benefits across different indications
  • Lower adverse effects
  • No dietary restrictions
  • Lower Drug-Drug Interactions
  • Rapid action
  • Without risk of HIT

Contact Us

Telegram
@Anticoagulation_Therapy
.
medinfo@arenalifescience.com
.
(+98) 910 587 77 17
دی ان ان